Revenue and gross profit were not disclosed for QQ3 2025 in the provided data. Key reported figures for QQ3 2025:
- Operating income: -$2,371,472,000
- Net income: -$2,536,292,000
- EBITDA: -$2,371,472,000
- Net income / EPS: -$2,536,292,000; EPS -$2,572.16 per share (weighted average shares: 986,057)
- Research and development expenses: $1,033,118,000
- Selling, general and administrative expenses: $1,338,354,000
- Interest expense: -$179,477,000
- Cash from operating activities: -$1,620,084,000 (note: unit appears as USD thousands in data, implying a negative cash flow of approximately $1.62 million if viewed at face value, though the scale suggests a more substantial cash burn when aligned to other line items)
- Free cash flow: -$1,635,785,000
- Cash at end of period: $2,596,522,000
- Current ratio: 0.978; Quick ratio: 0.796; Cash ratio: 0.727
- Total assets: $5,703,855,000; Total liabilities: $3,917,166,000; Total stockholders’ equity shows data inconsistencies (see below caveat)
Notes on usage and interpretation: Several balance-sheet fields appear misaligned or mislabeled (e.g., retained earnings, stockholders’ equity components, and some line-item magnitudes). Reported debt and cash positions suggest a complex labeling issue in the data source rather than a straightforward financial position. All figures are USD and, where possible, referenced to the provided quarter (QQ3 2025) and four-quarter context.